HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

4- cyano- 1- (2- iodophenyl)- 5- (4- methoxyphenyl)- N- (piperidin- 1- yl)- 1H- pyrazole- 3- carboxamide

structure in first source

Also Known As:

(125I)SD 7015; (125I)SD-7015; (125I)SD7015; SD 7015; SD-7015; SD7015

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrazoles: 61
      - 4-cyano-1-(2-iodophenyl)-5-(4-methoxyphenyl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide: 2

Experts

1.	Csiba, László: 2 articles (04/2012 - 02/2012)
2.	Farkas, Szabolcs: 2 articles (04/2012 - 02/2012)
3.	Gulyás, Balázs: 2 articles (04/2012 - 02/2012)
4.	Halldin, Christer: 2 articles (04/2012 - 02/2012)
5.	Harkany, Tibor: 2 articles (04/2012 - 02/2012)
6.	Jia, Zhisheng: 2 articles (04/2012 - 02/2012)
7.	Máthé, Domokos: 2 articles (04/2012 - 02/2012)
8.	Nagy, Katalin: 2 articles (04/2012 - 02/2012)
9.	Palkovits, Miklós: 2 articles (04/2012 - 02/2012)
10.	Donohou, Sean R: 1 article (04/2012)

Related Diseases

1.	Parkinson Disease (Parkinson's Disease) 04/10/2012 - "The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ antagonist [³H]raclopride and the novel CB₁ inverse agonist [¹²⁵I]SD7015."
2.	Alzheimer Disease (Alzheimer's Disease) 02/01/2012 - "[¹²⁵I]SD-7015 reveals fine modalities of CB₁ cannabinoid receptor density in the prefrontal cortex during progression of Alzheimer's disease."

Related Drugs and Biologics

1.	Cannabinoid Receptors (Cannabinoid Receptor)
2.	Raclopride
3.	Dopamine (Intropin)